On February 14, 2008, the Communications and Public Liaison Branch for the National Human Genome Res...
This is a preview of Toxicity and Pitfalls of Botox and Injectable Fillers: Avoiding Liability and E...
, physical therapy, acupuncture and traction. Often, these treatments only cover up the symptoms and...
In Afghanistan, millions of people are suffering the consequences of the conflict and repeated natur...
About the Video: Millions of women suffer from chronic pelvic pain. In this program, our expert, Dr....
PubMed |
(0) (0 Votes)
|
Views: (2) Date: (1996-5-1) Pages: () |
Abstract: Chronic toxicity of indium arsenide (InAs) and indium phosphide (InP) was studied in male Syrian golden hamsters which received InAs or InP particles containing a total dose of 7.5 mg of arsenic or phosphorus by intratracheal instillations once a week for 15 weeks. As a control, hamsters were treated with the vehicle, phosphate buffer solution. During their total life span, the cumulative body weight gain of hamsters in the InAs group was suppressed significantly compared with that in the control group, but not in the InP group when compared with that in the control group. Concerning the histopathological findings of the lung, the incidence rates of proteinosis-like lesions, alveolar or bronchiolar cell hyperplasia, pneumonia, emphysema and metaplastic ossification observed in the InAs or InP group were significantly higher than those observed in the control group. From these results, it would seem that InAs and InP produced severe damage to the lungs of hamsters.